News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement

Mary Rohrer

Advertisement

Articles by Mary Rohrer

An Inspiring, Guiding Light Through Lung Cancer

ByLeah “Cherry” Lommen,Mary Rohrer
August 7th 2021

"He strengthens you with the scientific knowledge he provides, with his courage as a role model and with his fighting spirit.”

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on CURE

    1

    Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

    2

    Key GI Cancer Advances from the 2026 ASCO Symposium

    3

    Ibrance Adds 15 Months of Progression-Free Survival in HR+, HER2+ Breast Cancer

    4

    Study Identifies Why Some Breast Cancers Resist Enhertu Treatment

    5

    Risk Assessment Remains Vital for Patients Even After Cancer Diagnosis

    • About Us
    • Advertise / Support
    • Editorial Board
    • Contact Us
    • CancerNetwork.com
    • TargetedOnc.com
    • OncLive.com
    • OncNursingNews.com
    • Terms & Conditions
    • Privacy
    • Do Not Sell My Information
    • Washington My Health My Data
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.